Hemophagocytic syndrome after living-related liver transplantation.
Hemophagocytic syndrome (HPS) is a life-threatening hematological disorder in immunocompromised patients. Although the number of patients with HPS following liver transplantation is scarce the outcome is usually fatal. We report a patient who developed HPS following living-related liver transplantation (LRLT) and was treated successfully by a combination of intravenous (IV) immunoglobulin (Ig) and granulocyte colony-stimulating factor (GCSF).
Karasu
Z
Z
Department of Gastroenterology, Ege University, Izmir, Turkey. zekikarasu@hotmail.com
Kilic
M
M
Cagirgan
S
S
Lebe
E
E
Yilmaz
F
F
Demirbas
T
T
Tokat
Y
Y
D000328:Adult; D001706:Biopsy; D003937:Diagnosis, Differential; D015614:Histiocytosis / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D006801:Humans; D016031:Liver Transplantation / Q000009:adverse effects* / Q000473:pathology; D019520:Living Donors; D008297:Male; D010956:Plasmapheresis